ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 120 • 2013 ACR/ARHP Annual Meeting

    The Symptom Severity In Korean Patients With Fibromyalgia Is Associated With Socioeconomic Status, But Not With Obesity

    Dong-Jin Park1, Shin-Seok Lee2, Seong-Ho Kim3, Seong-Su Nah4, Ji Hyun Lee5, Seong-Kyu Kim6, Yeon-Ah Lee7, Seung-Jae Hong7, Hyun-Sook Kim8, Hye-Soon Lee9, Hyoun Ah Kim10, Chung-Il Joung11 and Sang-Hyon Kim12, 1Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 2Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 3Internal Medicine, Division of Rheumatology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Maryknoll Medical Center, Busan, South Korea, 6Catholic University of Daegu School of Medicine, Daegu, South Korea, 7Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, 8Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University of Korea, Seoul, South Korea, 9Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, 10Ajou University Hospital, Suwon, South Korea, 11Department of Internal Medicine, Konyang university hospital, Daejeon, South Korea, 12Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

    Background/Purpose: Fibromyalgia (FM) is a chronic pain disorder characterized by widespread pain, tenderness, and various associated symptoms including sleep disturbances, chronic fatigue, depression, and other…
  • Abstract Number: 1106 • 2013 ACR/ARHP Annual Meeting

    Effectiveness Of Interdisciplinary Program For Fibromyalgia

    Dianne Whiting1, Debbi Huskey1, Emily Rosario1 and Samy Metyas1,2, 1Casa Colina Centers for Rehabilitation, Pomona, CA, 2University of Southern California, Keck School of Medicine, Assistant Clinical Professor Of Rheumatology, Covina, CA

    Background/Purpose: Fibromyalgia (FM) affects 5 million Americans, and the prevalence is estimated to be 2- 6 percent in the general population. The symptoms associated with…
  • Abstract Number: 121 • 2013 ACR/ARHP Annual Meeting

    Comparative Burden Of Chronic Widespread Pain and Fibromyalgia In The US Population

    Caroline Schaefer1, Rachael Mann2, Elizabeth T. Masters3, Joseph C. Cappelleri4, Shoshana Daniel5, Gergana Zlateva3, Heather McElroy6, Arthi B. Chandran3, Edgar H. Adams1, Annlouise R. Assaf4, Michael McNett7, Philip Mease8, Stuart L. Silverman9 and Roland Staud10, 1Covance Market Access Services Inc., Gaithersburg, MD, 2Covance Market Access Services Inc., San Diego, CA, 3Pfizer Inc., New York, NY, 4Pfizer Inc., Groton, CT, 5Covance Market Access Services Inc., Conshohocken, PA, 6Covance Market Access Services, Sydney, Australia, 7Aurora Pain Program, Milwaukee, WI, 8Director, Rheumatology Research, Swedish Medical Center, Seattle, WA, 9Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA, 10Dept Med/Rheum/Clin Immun Div, University of Florida, Gainesville, FL

    Background/Purpose: Few data exist on the comparative burden of chronic widespread pain (CWP) and fibromyalgia (FM) in the general population. Methods: 8,382 nationally representative participants…
  • Abstract Number: 1108 • 2013 ACR/ARHP Annual Meeting

    Methylphenidate Improves Concentration, Energy and Mood In Fibromyalgia

    Robert S. Katz1, Hannah Bond2 and Frank Leavitt3, 1Rush Medical College, Chicago, IL, 2Rheumatology Associates, Chicago, IL, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Central nervous system stimulants such as methylphenidate appear to have short term benefits for naming speed and cognitive functioning in fibromyalgia (FMS).  Methylphenidate quickly…
  • Abstract Number: 127 • 2013 ACR/ARHP Annual Meeting

    Clinical Application Of Pain Diagrams In Fibromyalgia

    Amanda Steele1, Dana Dailey2 and Kathleen Sluka2, 1Rheumatology, University of Iowa Hospitals and Clinics, Iowa City, IA, 2Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA

    Background/Purpose: Fibromyalgia is a condition characterized by chronic widespread pain.  Accurately assessing the subjective experience of pain using objective measures remains a challenging clinical problem,…
  • Abstract Number: 1091 • 2013 ACR/ARHP Annual Meeting

    Altered Intrinsic Brain Connectivity In The Salience Network Of Fibromyalgia Patients At Rest

    Seong-Ho Kim, Internal Medicine, Division of Rheumatology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, South Korea

    Background/Purpose: Recent studies employing resting-state functional magnetic resonance imaging (fMRI) have demonstrated altered intrinsic brain connectivity in patients with fibromyalgia (FM); however, few studies have…
  • Abstract Number: 130 • 2013 ACR/ARHP Annual Meeting

    Mindfulness Is Associated With Psychological Symptoms, Self-Efficacy and Quality Of Life Among Patients With Fibromyalgia

    Nani Morgan1, Lucas Morgan2, Lori Lyn Price3,4 and Chenchen Wang5, 1Internal Medicine Residency Program, University of Hawaii, Honolulu, HI, 2Clinical Psychology, University of Massachusetts, Honolulu, HI, 3Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 4Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 5Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Mindfulness is the ability to observe, describe, or be aware of present moment experiences without judgment or reactivity. Preliminary evidence suggests that interventions aimed…
  • Abstract Number: 1083 • 2013 ACR/ARHP Annual Meeting

    Something Ventured, Something Gained: Alternative Therapies For FMS and RA

    Robert S. Katz1, Hannah Bond2, Jessica L. Polyak2, Lauren Kwan2, Alexandra Small3 and Susan Shott4, 1Rush Medical College, Chicago, IL, 2Rheumatology Associates, Chicago, IL, 3University of Illinois Medical School, Chicago, IL, 4Rush University Medical Center, Chicago, IL

    Background/Purpose:   Many patients with rheumatologic diseases resort to unproven alternative therapies. We compared FMS and RA patients with respect to the use and effectiveness…
  • Abstract Number: 133 • 2013 ACR/ARHP Annual Meeting

    Cross-Sectional Neurocognitive Data Do Not Support a Transition From Fibrofog To Alzheimer’s Disease In Fibromyalgia Patients

    Robert S. Katz1 and Frank Leavitt2, 1Rush Medical College, Chicago, IL, 2Rush University Medical Center, Chicago, IL

    Background/Purpose: The issue of progressive decline in cognitive abilities is a source of concern to many patients with fibromyalgia.  The fear of progressing from fibrofog…
  • Abstract Number: 1084 • 2013 ACR/ARHP Annual Meeting

    Age Distribution of Women With Idiopathic and Traumatic Fibromyalgia

    Robert S. Katz1 and Frank Leavitt2, 1Rush Medical College, Chicago, IL, 2Rush University Medical Center, Chicago, IL

    Background/Purpose: Fibromyalgia has both idiopathic and post traumatic forms. The idiopathic type is insidious in onset, becoming established without a known triggering event.   The post-traumatic…
  • Abstract Number: 134 • 2013 ACR/ARHP Annual Meeting

    Lower Socioeconomic Status Associates With Increased Symptom Severity and Functional Impairment In Fibromyalgia

    Mary-Ann Fitzcharles1, Emmanouil Rampakakis2,3, Peter A. Ste-Marie4, John S. Sampalis2,3 and Yoram Shir4, 1Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 2JSS Medical Research, Montreal, QC, Canada, 3Jewish General Hospital, McGill University, Montreal, QC, Canada, 4Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Persons with lower socioeconomic status (SES) have poorer health status for many medical conditions. Reasons for this finding are multiple, but access to care,…
  • Abstract Number: 839 • 2013 ACR/ARHP Annual Meeting

    A Paradigm Change for Treatment Strategies for Fibromyalgia Syndrome Reflected By Recommendations of Recent Evidence-Based Interdisciplinary Guidelines Developed Independently in Three Countries

    Jacob N. Ablin1, Dan Buskila2, Howard Amital3, Mary-Ann Fitzcharles4, Yoram Shir5, Peter Henningsen6 and Winfried Häuser7, 1Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Ben-Gurion University, Beer-Sheva, Israel, 3Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, 4Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 5Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 6Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany, 7Klinikum Saarbrücken, Saarbrücken, Germany

    Background/Purpose: Although the ideal treatment for fibromyalgia (FM) remains elusive, the medical community requires direction in the care of these patients.  The literature however abounds…
  • Abstract Number: 136 • 2013 ACR/ARHP Annual Meeting

    The Detection Of Primary Hyperparathyroidism In Patients Diagnosed With Fibromyalgia

    Michael Tsoukas1, Peter A. Ste-Marie2, Yoram Shir2, Mary-Ann Fitzcharles3 and Elliot Mitmaker4, 1Endocrinology, McGill University Health Centre, Montreal, QC, Canada, 2Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 3Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 4General and Endocrine Surgery, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Some illnesses, such as hypothyroidism or small fiber neuropathy, may present similarly to fibromyalgia (FM), or may in turn lead to an augmented polysymptomatic…
  • Abstract Number: 841 • 2013 ACR/ARHP Annual Meeting

    The Prevalence Of Fibromyalgia In The General Population – a Comparison Of The ACR 1990, 2010 and Modified 2010 Classification Criteria

    Gareth T. Jones1, Marcus Beasley1, Fabiola Atzeni2, Elisa Flüß1, Piercarlo Sarzi-Puttini2 and Gary Macfarlane1, 1Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Rheumatology Unit, L. Sacco University Hospital, Milan, Italy

    Background/Purpose: In 1990 the ACR published criteria for the classification of fibromyalgia (FM), based on widespread pain and tenderness.  In 2010 new criteria were published…
  • Abstract Number: 842 • 2013 ACR/ARHP Annual Meeting

    A Cytokine/Chemokine Multiplex Assay That Is Sensitive and Specific For Fibromyalgia Compared To Controls, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Daniel J. Wallace1, Igor Gavin2, Oleksiy Karpenko2 and Bruce S. Gillis3, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2University of Illinois College of Medicine at Chicago, Chicago, IL, 3Department of Pathology, University of Illinois College of Medicine at Chicago, Chicago, IL

    Background/Purpose:   Fibromyalgia (FM) is a chronic pain and fatigue syndrome that affects about 6 million adults in the United States.  The clinical diagnosis of…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology